novo nordisk glp-1 patent litigation scores court win against copycat compounders Natco vs Novo: GLP-1 patents
Description
GLP-1 injectable medications, such as Ozempic and Wegovy, are only available by prescription
Misleading marketing
The same receptor can also mobilize intracellular calcium and activate the ERK pathway, giving GLP-1 a signaling repertoire broader than cyclic AMP alone
Our specially trained nurses, pharmacists, and toxicologist can provide the most up-to-date information regarding exposures and treatment
Eli Lilly and Novo Nordisk have both announced ambitious investments in new and existing facilities to ramp up production of oral and traditional injectables, in part to accommodate for the expansion in medical coverage
